Only about 20% of patients respond to PD-1 checkpoint inhibitors, making response prediction one of the biggest challenges in oncology today. Join scientists from Mithrl and Elephas for a webinar exploring how functional tumor profiling and agentic AI can be combined to uncover the immune signatures that drive response to immunotherapy. Using data from 131 human tumor specimens, the speakers will discuss how real-time cytokine measurements from live tumor biopsies can be combined with genomic data to support biomarker discovery and patient stratification. Featured speakers: • Erika von Euw, PhD, MBA, Vice President of Scientific Affairs, Elephas Biosciences • Ada Shaw, PhD, Head of Scientific Partnerships, Mithrl Key topics include: ✔ Predicting response to immune checkpoint inhibitors ✔ Biomarker strategy and patient selection ✔ Functional tumor profiling with Elephas' elive™ platform ✔ AI-powered integration of multimodal biological data with Mithrl's Scientific Decision Engine Register here: bit.ly/4uKFhSn #Oncology #Immunotherapy #DrugDiscovery #Biomarkers #PrecisionMedicine #Biopharma #LifeSciences @GenomeWeb @ecolienthusiast

We've all been there. 😅 What's the longest you've ever waited for a data analysis to finish? 👇

#ThrowbackThursday to #AACR26, where we had the opportunity to present our collaborative research with Elephas on multi-agent-augmented analysis of PD-1 checkpoint inhibitor response. Our research demonstrated how integrating functional cytokine profiling and transcriptomics with a multi-agent AI approach can identify immune phenotypes associated with response to PD-1 checkpoint inhibitors, providing new insights to support biomarker discovery in immuno-oncology. Next Thursday, we'll take a deeper dive into these findings during a @GenomeWeb webinar, "An Agentic AI Approach to Predicting Immunotherapy Response." Join Erika von Euw, PhD, MBA, Vice President of Scientific Affairs at Elephas, and Ada Shaw, PhD, Head of Scientific Partnerships at Mithrl. 📅 Thursday, July 16 🕛 12:00 PM ET | 9:00 AM PT | 6:00 PM CET Reserve your spot: bit.ly/4uKFhSn Can't attend live? Register to receive the recording.

Drug discovery has never had more data, yet turning that data into actionable insights remains a challenge. In your opinion, what is the biggest challenge in drug discovery today? Share your perspective in the comments. #DrugDiscovery #AI #Biotech #ComputationalBiology #LifeSciences

Have you registered for our upcoming webinar with Elephas next week? Join Ada Shaw, PhD, and Erika von Euw, PhD, MBA, to learn how agentic AI and functional tumor profiling can improve immunotherapy response prediction. We hope to see you there! bit.ly/448ikO8 #Oncology #Immunotherapy #DrugDiscovery #Biomarkers #PrecisionMedicine #Biopharma #LifeSciences @GenomeWeb @ecolienthusiast

What if you could turn months of single-cell analysis into just days? That's exactly what one clinical-stage cell therapy company achieved with Mithrl's Scientific Decision Engine. The result? Novel IP, faster insights, and accelerated drug discovery. Read the case study: bit.ly/4wcFa2S

To everyone in the U.S. celebrating the Fourth of July, we wish you a relaxing and enjoyable holiday weekend. Happy Fourth of July from the Mithrl team! #FourthofJuly #IndependenceDay

Complex omics data shouldn't slow scientific discovery. At #ABRF2026, we were honored to present "An Agentic AI Scientific Decision Engine for Omics: Bridging Core Lab and End User," a scientific poster authored and presented by Ada Shaw, PhD, Scientific Partnerships Lead at Mithrl. The poster highlights how Mithrl's Scientific Decision Engine helps researchers address the growing complexity of biological data through transparent, reproducible, and AI-driven analysis, featuring case studies in heart organoid development and Alzheimer's disease. Download the poster to learn more: bit.ly/4eZJexG #Omics #Bioinformatics #DrugDiscovery #LifeSciences #AgenticAI @MyABRF @ecolienthusiast

What if we could identify which patients are most likely to benefit from immunotherapy before treatment begins? Only about 20% of patients respond to PD-1 checkpoint inhibitors, making patient stratification one of the biggest challenges in oncology. Join scientists from Mithrl and Elephas Biosciences for a @GenomeWeb webinar exploring how functional tumor profiling and agentic AI can identify the immune signatures associated with treatment response. Using data from 100+ human tumor specimens, this session will demonstrate how real-time measurements of cytokine proteins from live tumor biopsies can be integrated with transcriptomic data to support biomarker discovery and more informed subject selection. Featured speakers: • Erika von Euw, PhD, MBA, Vice President of Scientific Affairs, Elephas Biosciences • Ada Shaw, PhD, Head of Scientific Partnerships, Mithrl Key topics: ✔ Predicting response to immune checkpoint inhibitors ✔ Biomarker strategies for patient stratification ✔ Functional tumor profiling with Elephas' elive™ platform ✔ AI-powered integration of multimodal biological data with Mithrl's Scientific Decision Engine 📅 Thursday, July 16 🕛 12:00 PM ET | 9:00 AM PT | 6:00 PM CET Register today: bit.ly/4uKFhSn #Oncology #Immunotherapy #DrugDiscovery #Biomarkers #PrecisionMedicine #Biopharma @ecolienthusiast

Curious how Mithrl turns complex biological data into defensible scientific decisions? Watch the short demo of our Scientific Decision Engine below to see how trustworthy AI helps biopharma teams move from raw data to decision-ready insights faster.

What if a deeper understanding of a single gene could transform our understanding of Alzheimer's disease? New research highlighted by @TheScientistLLC suggests #APOE variants may influence a far greater proportion of Alzheimer's cases than previously recognized. Discoveries like this underscore why modern drug discovery requires integrating evidence across genetics, molecular pathways, and clinical research to generate actionable scientific insight. bit.ly/4eeFPJY #AlzheimersAwarenessMonth #DrugDiscovery #Multiomics #Neuroscience

Today is the final day of #BIO2026! If you're attending, stop by Booth #1525 in the @Biocom CA Pavilion before the exhibit hall closes at 4:00 PM to see a live demo of Mithrl's Scientific Decision Engine, explore how agentic AI is accelerating drug discovery, and pick up some Mithrl swag while you're there. Thank you to everyone who has visited our booth or joined us for our events this week. It's been a pleasure connecting with the biotech and life sciences community, and we look forward to continuing the conversation beyond BIO. Not attending BIO? Book an online demo of our Scientific Decision Engine: bit.ly/4pgzmlJ @Ames24704 @LugtRachel38704 @flyingthor @IAmBiotech

As we closed out Day 3, there were no signs of slowing down. Welcome to Day 4 - the final lap of #BIO2026!

Attending #BIO2026 this week? There's still time to register for our AI + Biopharma Dinner Cruise! Join leaders across biotech and life sciences for an evening of networking and conversation as we explore how AI is accelerating discovery and shaping the future of drug development while cruising San Diego Bay. 📅 Wednesday, June 24 | 6:30-9:30 PM 📍 San Diego Harbor (just 2.5 miles from the San Diego Convention Center) Before you head to the harbor, stop by Booth #1525 in the @Biocom California Pavilion to meet the Mithrl team, see a live demo of our Scientific Decision Engine, and pick up some Mithrl swag. Register and learn more: bit.ly/4xvDseG We look forward to connecting with you both on the exhibit floor and aboard the dinner cruise.

Join us tonight for BIO Bash, the Golden Hour reception at #BIO2026. Set against San Diego's waterfront, this @Biocom reception brings together the global life sciences community for an evening of networking, collaboration, and conversation. Mithrl is proud to be a co-sponsor of this highly anticipated BIO week event. 📍 EVE at RaDD, San Diego 🕠 Tuesday, June 23 | 5:30 PM – 8:30 PM PDT To everyone attending, we look forward to connecting with colleagues, partners, and innovators from across biotech, biopharma, and life sciences. See you at Golden Hour. bit.ly/4xvDseG @IAmBiotech @Ames24704 @LugtRachel38704 @flyingthor

Day 2 at #BIO2026 is underway! If you're attending BIO this week, stop by the @Biocom CA Pavilion (Booth #1525) to meet the Mithrl team and see how our Scientific Decision Engine helps researchers translate complex data into transparent, defensible scientific decisions. Whether you're interested in AI for drug discovery, looking to learn more about Mithrl, or checking out the CA Pavilion's event schedule, we'd love to connect. While you're in the pavilion, be sure to check out today's schedule of events, including the @MilliporeSigma North American Advance Biotech Grant Award Ceremony happening today from 11:00-11:30 AM PDT, celebrating emerging biotech innovation. View the full CA Pavilion schedule: bit.ly/44qNXSU Say hello to the Mithrl team, including Lee Miller, Sarosh Naseem, Rachel van der Lugt, Allegra Messinese, and Vivek Adarsh. @IAmBiotech @Ames24704 @LugtRachel38704 @flyingthor

👋 San Diego - we're here! Here's to an incredible week at #BIO2026

🚀 It's officially Day 1 of #BIO2026! Visit Mithrl at Booth #1525 in the @Biocom CA Pavilion to discover how we're helping biopharma teams turn complex data into defensible scientific decisions. Experience live demos, connect with our team, and pick up Mithrl swag while you're there. We're also hosting and co-sponsoring networking events throughout the week, including the Golden Hour Biocom Reception and our AI + Biopharma Dinner Cruise. Learn more: bit.ly/4xvDseG @IAmBiotech @Ames24704 @LugtRachel38704 @flyingthor

With a nod to @leopoldasch, we're releasing Biological Awareness - our musings on the next decade at the frontiers of AI and life sciences. Six ideas we explore: → Task-specific experimental tokens are the new gold in biology → Bio AI data factories will pioneer new business models → Smoothing out the jagged frontier for pharma enterprises is where fortunes will be made → Clinical trial intelligence will be financialized before it is operationalized → The bioweapons threat is real, accelerating, and underpriced → The BIOSECURE Act will fundamentally reshape supply chains 2026 marks ten years of Obvious investing at this intersection. A lot has happened. Even more is coming. Big thanks to: @kyosu, @syntenyAI, @GabriCorso, @inductivebio, @mithrl_ai , @instancebio , @strangemonad, @exnx and many others for their help!

Looking forward to #BIO2026!